Mexico: Mexico's COVID-19 Vaccination Program - The Federal government establishes the conditions for the participation of local governments and private sector

In brief

After having rejected initially any possibility in this regard, the Federal Ministry of Health (“MoH”) issued a Decree, published in the Official Gazette on 25 January 20211 establishing the conditions under which the local (State) governments and the private sector, can participate in the National Vaccination Program for COVID-19. Although it does not eliminate many uncertainties, it opens certain possibilities of action.


Contents

Key takeaways

Companies who had planned to acquire vaccines for their employees should carefully review both implicit and explicit conditions found in this Decree, which should be read together with the National Vaccination Policy2. Noteworthy, not all of the models that some stakeholders in the private sector had suggested publicly before, would now be consistent with this Decree.

In more detail

The Decree reflects a policy change regarding the initial rejection of the Federal government to allow local governments and the private sector to participate in the acquisition, import, distribution and application of COVID-19 vaccines in Mexico.

However, this instrument does not address all key aspects or eliminate all relevant uncertainties, leaving some key questions still open. For example, the Decree does not: (i) refer to those non-healthcare related companies who want to participate; or (ii) refer to important product authorizations, such as marketing authorizations or import permits.

On the other hand, the Decree does require:

  • sharing the purchase agreement with the MoH
  • sharing data on doses and applications with the MoH
  • respecting the roll-out criteria and calendar defined by the Federal MoH
  • comply with measures to be defined by the Federal MoH
  • guarantee traceability and share periodic reports with the MoH

Our Healthcare and Life Sciences Industry Group can support companies to review their plans to acquire vaccines for their employees in the light of this key normative development. We can help them devise and implement a strategy to have access to these important treatments as soon as possible, in a way that can be complaint with the current legal and regulatory framework.

#LifeSciencesBakerMcKenzie


1 Available here: http://dof.gob.mx/nota_detalle.php?codigo=5610327&fecha=25/01/2021

2 Available here: https://coronavirus.gob.mx/wp-content/uploads/2021/01/PolVx_COVID_-11Ene2021.pdf

Contact Information
Christian Lopez-Silva
Partner, Head of Healthcare & Life Sciences
Mexico City
christian.lopez-silva@bakermckenzie.com

Copyright © 2022 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.